Kavar Capital Partners Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $211K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $972K | Sell |
|
|||||
|
2024
Q3 | $1.33M | Sell |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.44M | Sell |
|
|||||
|
2023
Q4 | $1.48M | Sell |
|
|||||
|
2023
Q3 | $1.83M | Buy |
|
|||||
|
2023
Q2 | $1.76M | Sell |
|
|||||
|
2023
Q1 | $1.89M | Sell |
|
|||||
|
2022
Q4 | $1.93M | Sell |
|
|||||
|
2022
Q3 | $1.78M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.8M | Buy |
|
|||||
|
2021
Q4 | $2.78M | Buy |
|
|||||
|
2021
Q3 | $2.38M | Buy |
|
|||||
|
2021
Q2 | $2.38M | Sell |
|
|||||
|
2021
Q1 | $2.18M | Buy |
|
|||||
|
2020
Q4 | $2.23M | Buy |
|
|||||
|
2020
Q3 | $2.19M | Buy |
|
|||||
|
2020
Q2 | $2.17M | Buy |
|
|||||
|
2020
Q1 | $1.9M | Buy |
|
|||||
|
2019
Q4 | $2.33M | Sell |
|
|||||
|
2019
Q3 | $2.13M | Sell |
|
|||||
|
2019
Q2 | $2M | Buy |
|
|||||
|
2019
Q1 | $1.98M | Buy |
|
|||||
|
2018
Q4 | $1.79M | Sell |
|
|||||
|
2018
Q3 | $1.91M | Buy |
|
|||||
|
2018
Q2 | $1.91M | Buy |
|
|||||
|
2018
Q1 | $1.84M | Buy |
|
|||||
|
2017
Q4 | $383K | Sell |
|
|||||
|
2017
Q3 | $1.82M | Sell |
|
|||||
|
2017
Q2 | $1.95M | Sell |
|
|||||
|
2017
Q1 | $1.95M | Buy |
|
|||||
|
2016
Q4 | $1.63M | Buy |
|
|||||
|
2016
Q3 | $1.73M | Buy |
|
|||||
|
2016
Q2 | $1.63M | Buy |
|
|||||
|
2016
Q1 | $1.52M | Buy |
|
|||||
|
2015
Q4 | $1.39M | Sell |
|
|||||
|
2015
Q3 | $1.58M | Buy |
|
|||||
|
2015
Q2 | $1.54M | Buy |
|
|||||
|
2015
Q1 | $1.63M | Buy |
|
|||||
|
2014
Q4 | $1.43M | Buy |
|
|||||
|
2014
Q3 | $1.52M | Buy |
|
|||||
|
2014
Q2 | $920K | Buy |
|
|||||
|
2014
Q1 | $668K | Buy |
|
|||||
|
2013
Q4 | $569K | Buy |
|